Stock Research Monitor: PGNX, PLX, and RDUS

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on PBYI sign up now at www.wallstequities.com/registration. For today, WallStEquities.com presents the following stocks for evaluation: Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Protalix BioTherapeutics Inc. (NYSE AMER: PLX), Puma Biotechnology Inc. (NASDAQ: PBYI), and Radius Health Inc. (NASDAQ: RDUS). These companies are part of the Biotech industry, which broadly segments into the medical and agricultural markets. Although enterprising biotechnology is also being applied to other exciting areas like industrial production of chemicals, and bioremediation, the use in these areas is still specialized and limited. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Progenics Pharmaceuticals

Shares in New York City, New York-based Progenics Pharmaceuticals Inc. saw a decline of 3.09%, ending Wednesday’s trading session at $8.16. The stock recorded a trading volume of 936,961 shares. The Company’s shares have gained 8.95% in the last month, 10.72% over the last three months, and 18.26% over the past year. The stock is trading 6.11% and 20.45% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Progenics Pharma, which develops medicines and other technologies to target and treat cancer in the US and internationally, have a Relative Strength Index (RSI) of 50.16.

On June 26th, 2018, Progenics Pharma announced that it has completed enrollment in its Phase-2/3 OSPREY clinical trial evaluating the diagnostic accuracy of its PSMA-targeted PET/CT imaging agent, PyL™ (18F-DCFPyL), in prostate cancer. Get the full research report on PGNX for free by clicking below at:

www.wallstequities.com/registration/?symbol=PGNX

Protalix BioTherapeutics

Karmiel, Israel-based Protalix BioTherapeutics Inc.’s stock declined 2.08%, closing the day at $0.44 with a total trading volume of 159,028 shares. The stock is trading 0.70% below their 50-day moving average. , which focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally, Shares of the company, which focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally, have an RSI of 45.14.

On June 05th, 2018, Protalix BioTherapeutics announced that additional positive results from the Company’s phase II clinical trial of OPRX-106 for the treatment of ulcerative colitis were presented at the Digestive Disease Week® 2018 Annual Meeting. OPRX-106 is a plant cell-expressed recombinant human tumor necrosis factor receptor II fused to an IgG1 Fc domain (TNFRII-Fc) in development for oral administration. Access the free research report on PLX now by signing up at:

www.wallstequities.com/registration/?symbol=PLX

Puma Biotechnology

On Wednesday, shares in Los Angeles, California headquartered Puma Biotechnology Inc. recorded a trading volume of 2.21 million shares, which was higher than their three months average volume of 852,550 shares. The stock ended the day 10.62% lower at $56.80. The Company’s shares have advanced 10.08% in the past month. The stock is trading above its 50-day moving average by 0.75%. Furthermore, shares of Puma Biotechnology, which focuses on the development and commercialization of products to enhance cancer care in the US, have an RSI of 53.38.

On June 26th, 2018, Puma Biotechnology announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive trend vote recommending the approval of the Marketing Authorisation Application (MAA) for neratinib for the extended adjuvant treatment of early stage HER2-positive hormone receptor positive breast cancer. The decision follows a reexamination of the negative opinion announced by the CHMP at its formal meeting with the Company to discuss the MAA on February 23rd, 2018. Are you already registered with Wall St. Equities? Do so now for free, and get the report on PBYI at:

www.wallstequities.com/registration/?symbol=PBYI

Radius Health

Waltham, Massachusetts headquartered Radius Health Inc.’s stock dropped 3.46%, finishing yesterday’s session at $27.94 with a total trading volume of 514,841 shares. The stock is trading below their 50-day moving average by 9.35%. Shares of the Company, which develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology, have an RSI of 39.52. Aspiring Member, please take a moment to register below for your free research report on RDUS at:

www.wallstequities.com/registration/?symbol=RDUS

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St Equities

ReleaseID: 503968

Stock Research Monitor: GG, HL, and IAG

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on HMY sign up now at www.wallstequities.com/registration. Featured today on WallStEquities.com is the Gold industry, which comprises companies that are engaged in the exploration and production of gold from mines. These companies are generally structured as corporations and have profits that are positively correlated with the price of gold. Under observation this morning are the following fours stocks: Goldcorp Inc. (NYSE: GG), Harmony Gold Mining Co. Ltd (NYSE: HMY), Hecla Mining Co. (NYSE: HL), and IAMGOLD Corp. (NYSE: IAG).

www.wallstequities.com/registration

Goldcorp

On Wednesday, shares in Vancouver, Canada headquartered Goldcorp Inc. recorded a trading volume of 3.83 million shares. The stock ended at $13.27, declining 1.26% from the last trading session. The Company’s shares are trading below their 200-day moving average by 1.08%. Furthermore, shares of Goldcorp, which acquires, explores for, develops, and operates precious metal properties in Canada, the US, Mexico, and Central and South America, have a Relative Strength Index (RSI) of 37.22.

On June 13th, 2018, Goldcorp announced that it will release its Q2 2018 results after market close on July 25th, 2018. The Company will host a conference call and webcast on July 26th, 2018, at 10:00 a.m. PT. A live and archived webcast will be available on the Company’s website. Get the full research report on GG for free by clicking below at:

www.wallstequities.com/registration/?symbol=GG

Harmony Gold Mining

Randfontein, South Africa-based Harmony Gold Mining Co. Ltd’s stock finished yesterday’s session flat at $1.55. A total volume of 4.72 million shares was traded, which was above their three months average volume of 4.30 million shares. The Company’s shares are trading below their 50-day moving average by 13.75%. Furthermore, shares of the Company, which engages in the exploration and mining of gold in South Africa and Papua New Guinea, have an RSI of 32.91. The free technical report on HMY can be accessed at:

www.wallstequities.com/registration/?symbol=HMY

Hecla Mining

At the close of trading on Wednesday, shares in Coeur d’Alene, Idaho headquartered Hecla Mining Co. saw a decline of 3.81%, ending the day at $3.53. The stock recorded a trading volume of 3.91 million shares, which was above its three months average volume of 3.68 million shares. The Company’s shares are trading 8.62% below their 50-day moving average. Moreover, shares of Hecla Mining, which together with its subsidiaries, discovers, acquires, develops, and produces precious and base metal deposits worldwide, have an RSI of 29.67. Sign up for free on Wall St. Equities and claim the latest report on HL at:

www.wallstequities.com/registration/?symbol=HL

IAMGOLD

Toronto, Canada headquartered IAMGOLD Corp.’s shares ended the day 2.09% lower at $5.62 with a total trading volume of 2.32 million shares. The stock has gained 8.91% over the previous three months and 9.34% over the past year. The Company’s shares are trading 2.11% below their 200-day moving average. Additionally, shares of IAMGOLD, which explores for, develops, and operates gold mining properties in North and South America, and West Africa, have an RSI of 40.39.

On June 05th, 2018, IAMGOLD announced positive results from a pre-feasibility study for its Essakane Heap Leach Project in Burkina Faso, West Africa. The results, which outline an economically viable project, justify the commencement of a feasibility study to further optimize the project development design, secure long lead equipment, and improve project economics.

On June 07th, 2018, research firm Desjardins downgraded the Company’s stock rating from ‘Buy’ to ‘Hold’. See the free research coverage on IAG at:

www.wallstequities.com/registration/?symbol=IAG

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503962

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want access to our free earnings report on Workday, Inc. (NASDAQ: WDAY), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=WDAY. The Company reported its financial results on May 31, 2018, for the first quarter of the fiscal year 2019, ended April 30, 2018. The Company surpassed analysts’ estimates for earnings and revenues in Q1 FY19. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Workday most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=WDAY

Earnings Highlights and Summary

For Q1 FY19, Workday’s net sales reached $618.64 million, reflecting an increase of 28.92% from $479.86 million in Q1 FY18, driven by a strong adoption and notable deployments of the Company’s finance and HR applications across customer sizes, geographies, and industries. The Company’s revenue numbers exceeded analysts’ consensus estimates of $609 million.

For the quarter under review, Workday’s subscription services revenues advanced 30.62% to $522.15 million on a y-o-y basis, while its professional services revenues jumped 20.43% to $96.49 million on a y-o-y basis.

During Q1 FY19, Workday’s total cost and expenses were $689.91 million, 27.75% higher than $540.06 million in Q1 FY18. For the reported quarter, the Company’s product development expenses increased 34.18% to $263.58 million on a y-o-y basis, while its sales and marketing expenses jumped 23.80% to $192.77 million on a y-o-y basis. Workday reported an operating loss of $71.26 million in the reported quarter compared to $60.20 million in the previous year’s same quarter.

Workday had a net loss of $74.41 million in the quarter ended April 30, 2018, versus a net loss of $64.04 million in the comparable period of last year. The Company’s net loss per share also widened to $0.35 in Q1 FY19 from $0.31 in Q1 FY18. The Company’s reported earnings included share based compensation expenses, other operating expenses, and amortization of debt discount and issuance costs. Excluding these special items, Workday had an adjusted net income per share of $0.33 in the reported quarter, an increase of 13.79% from $0.29 in the prior year’s corresponding quarter. This was higher than analysts’ consensus estimates of $0.26 per share.

Cash Matters

Workday had a total cash, cash equivalents, and restricted cash balance of $1.04 billion as on April 30, 2018, an increase of 107.03% from $501.10 million as on April 30, 2017.

For the quarter ended April 30, 2018, Workday’s cash flow from operating activities was $184.23 million, 2.34% higher than $180.02 million in the corresponding period of last year. The Company had a free cash flow of $135.37 million in Q1 FY19, down 9.41% on a y-o-y basis.

Workday incurred a capital expenditure, excluding owned real estate projects, of $48.86 million in Q1 FY19 compared to $30.59 million in Q1 FY18, reflecting an increase of 59.72%.

Outlook

Based on the strong first quarter results, Workday raised its guidance for the full fiscal year 2019. The Company now expects subscription revenues of $2.28 billion to $2.29 billion for FY19, which implies a growth of 27% to 28% on a y-o-y basis. The Company expects subscription revenues to be between $557 million and $559 million for Q2 FY19, implying a growth of 28% to 29% on a y-o-y basis.

Stock Performance Snapshot

June 27, 2018 – At Wednesday’s closing bell, Workday’s stock dropped 3.37%, ending the trading session at $117.72.

Volume traded for the day: 2.21 million shares, which was above the 3-month average volume of 1.76 million shares.

Stock performance in the previous six-month period – up 14.37%; past twelve-month period – up 19.68%; and year-to-date – up 15.71%

After yesterday’s close, Workday’s market cap was at $26.18 billion.

The stock is part of the Technology sector, categorized under the Application Software industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 503955

Stock Research Monitor: AGRO, BG, and SEED

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on ADM sign up now at www.wallstequities.com/registration. In today’s pre-market research, WallStEquities.com scans Adecoagro S.A. (NYSE: AGRO), Archer-Daniels-Midland Co. (NYSE: ADM), Bunge Ltd (NYSE: BG), and Origin Agritech Ltd (NASDAQ: SEED). Farm Products companies are engaged in the manufacture, marketing, and distribution of goods and supplies, such as fertilizers, sod, grains, and fruit and vegetable transplants, that are required by consumers and other segments of the agriculture industry. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Adecoagro

On Wednesday, shares in Luxembourg City, Luxembourg-based Adecoagro S.A. recorded a trading volume of 538,372 shares. The stock ended the session 1.75% lower at $8.40. The Company’s shares have gained 6.19% in the last month and 14.60% over the previous three months. The stock is trading 4.71% above its 50-day moving average. Moreover, shares of Adecoagro, which engages in farming crops and other agricultural products, dairy operations, sugar, ethanol and energy production, and land transformation activities in South America, have a Relative Strength Index (RSI) of 54.08. Get the full research report on AGRO for free by clicking below at:

www.wallstequities.com/registration/?symbol=AGRO

Archer-Daniels-Midland

Chicago, Illinois headquartered Archer-Daniels-Midland Co.’s stock closed the day 0.09% higher at $46.27 with a total trading volume of 3.08 million shares. The Company’s shares have advanced 5.66% in the past month, 8.11% in the previous three months, and 12.85% over the past year. The stock is trading 2.87% and 8.30% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Archer-Daniels-Midland, which procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the US and internationally, have an RSI of 60.96. Free research on ADM can be accessed at:

www.wallstequities.com/registration/?symbol=ADM

Bunge

Shares in White Plains, New York headquartered Bunge Ltd recorded a trading volume of 1.31 million shares. The stock ended yesterday’s trading session 1.20% lower at $70.07. The Company’s shares have advanced 0.59% in the past month. The stock is trading below its 50-day moving average by 1.34%. Furthermore, shares of Bunge, which operates as an agribusiness and food company worldwide, have an RSI of 46.03.

On May 31st, 2018, Bunge North America, the North American operating arm of Bunge, announced that it has opened its new wheat mill in the southeast region of Mexico. The Del Mayab mill is located 20 kilometers from Puerto Progresso, a strategic location for serving key customers in southeast Mexico. Visit WallStEquities.com now and sign up for the free research on BG at:

www.wallstequities.com/registration/?symbol=BG

Origin Agritech

Beijing, China headquartered Origin Agritech Ltd’s stock finished Wednesday’s session 3.85% lower at $0.75 with a total trading volume of 180,411 shares. The Company’s shares have advanced 4.02% in the last month. The stock is trading above its 50-day moving average by 4.60%. Additionally, shares of Origin Agritech, which engages in crop seed breeding and genetic improvement activities in China, have an RSI of 50.86. The free technical report on SEED is available at:

www.wallstequities.com/registration/?symbol=SEED

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503958

LONDON, UK / ACCESSWIRE / June 28, 2018 / Active-Investors has a free review on Air Products and Chemicals, Inc. (NYSE: APD) following the Company’s announcement that it will begin trading ex-dividend on June 29, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on June 28, 2018. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on APD:

www.active-investors.com/registration-sg/?symbol=APD

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On May 16, 2018, Air Products’ Board of Directors declared a quarterly dividend of $1.10 per share of common stock. The dividend is payable on August 13, 2018, to shareholders of record at the close of business on July 02, 2018.

Air Products’ indicated dividend represents a yield of 2.82%, which is substantially higher than the average dividend yield of 2.24% for the Basic Materials sector. The Company has increased its dividend for thirty-five consecutive years.

Dividend Insights

Air Products has a dividend payout ratio of 59.7%, which means that the Company spends approximately $0.60 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

As per analysts’ estimates, Air Products is forecasted to report earnings of $8.18 per share for the next year, which is substantially higher than the Company’s annualized dividend payout of $4.40 per share.

As of March 31, 2018, Air Products’ cash and cash items totaled $3.07 billion compared to $3.27 billion as on September 30, 2017. For the six months ended March 31, 2018, the Company’s net cash provided by operating activities was $1.11 billion compared to $861.2 million for the year ago corresponding period. The Company’s strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

Recent Development for Air Products

On June 22, 2018, Air Products announced that effective July 01, 2018, or as contracts permit, the Company will increase product pricing and surcharges for merchant customers in North America. The pricing adjustments include increases of, up to 20% for liquid and bulk helium, up to 15% for liquid argon, and microbulk, and up to 10% for liquid and bulk hydrogen.

Air Products stated that these adjustments are in response to the cost impact associated with the continued low operating rates in the steel market, increasing operational costs and delivery costs associated with specific regional supply and demand imbalances.

About Air Products and Chemicals, Inc.

Air Products is a world-leading Industrial Gases company in operation for over 75 years. The Company’s core industrial gases business provides atmospheric and process gases and related equipment to manufacturing markets, including refining and petrochemical, metals, electronics, and food and beverage. Air Products is also the world’s leading supplier of liquefied natural gas process technology and equipment.

The Company had fiscal 2017 sales of $8.2 billion from continuing operations in 50 countries and has a current market capitalization of about $35 billion.

Stock Performance Snapshot

June 27, 2018 – At Wednesday’s closing bell, Air Products and Chemicals’ stock was slightly down 0.45%, ending the trading session at $155.16.

Volume traded for the day: 793.07 thousand shares.

Stock performance in the past twelve-month period – up 7.88%

After yesterday’s close, Air Products and Chemicals’ market cap was at $34.04 billion.

Price to Earnings (P/E) ratio was at 25.92.

The stock has a dividend yield of 2.84%.

The stock is part of the Basic Materials sector, categorized under the Chemicals – Major Diversified industry. This sector was up 0.4% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 503952

Stock Monitor: Determine Post Earnings Reporting

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want access to our free earnings report on Zuora, Inc (NYSE: ZUO), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ZUO. The Company reported its first quarter fiscal 2019 operating and financial results on May 31, 2018. The business-subscription software Company reported better than expected results. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Determine, Inc. (NASDAQ: DTRM), which also belongs to the Technology sector as the Company Zuora. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=DTRM

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Zuora most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ZUO

Earnings Highlights and Summary

For its first fiscal quarter ended April 30, 2018, Zuora’s total revenues were $51.7 million, reflecting an increase of 60% compared to $32.3 million in Q1 FY18. The Company’s revenue numbers beat analysts’ estimates of $49.0 million.

During Q1 FY19, Zuora’s subscription revenues surged 39% to $36.1 million compared to $26.1 million in Q1 FY18.

For Q1 FY19, Zuora’s GAAP loss from operations was $18.6 million compared to a loss of $8.0 million in Q1 FY18. The Company’s non-GAAP loss from operations was $13.6 million in the reported quarter compared to a non-GAAP loss from operations of $6.5 million in the prior year’s same quarter.

Zuora’s GAAP net loss was $19.4 million, or $0.43 loss per share, based on 44.9 million weighted average shares outstanding, in Q1 FY19 compared to a loss of $8.1 million, or $0.33 loss per diluted share, based on 25.0 million weighted average shares outstanding, in Q1 FY18.

For Q1 FY19, Zuora’s non-GAAP net loss was $14.5 million, or $0.32 loss per diluted share, compared to a loss of $6.6 million, or $0.27 loss per diluted share, in Q1 FY18. The Company’s revenue numbers were better than Wall Street’s estimates of $0.40 per share.

Cash Matters

Zuora’s net cash used in operating activities was $7.8 million compared to $4.4 million in Q1 FY18. The Company’s free cash flow was negative $9.6 million compared to negative $5.1 million in the prior year’s corresponding quarter.

As of April 30, 2018, Zuora’s cash and cash equivalents and restricted cash balance was $207.7 million.

Zuora ended the quarter with 441 customers with ACV equal to or greater than $100,000, representing a growth of 6% q-o-q in such customers, and a net add of 26 of such customers.

Dollar-based retention rate increased to 112% q-o-q, primarily driven by a strong volume upsell activity.

Customer usage of Zuora solutions grew, with $7.2 billion in transaction volume through Zuora’s billing platform, reflecting an increase of 46% y-o-y.

Zuora completed its Initial Public Offering and began trading on the New York Stock Exchange on April 12, 2018, raising a total of $162.2 million in net proceeds.

Financial Outlook

For the second quarter of the fiscal year 2019, Zuora is forecasting total revenues of $53.5 million to $54.5 million. The Company is expecting subscription revenues of $38.0 million to $38.5 million, and non-GAAP loss from operations of $16.0 million to $15.0 million. Zuora is estimating non-GAAP net loss per share to be in the range of $0.16 to $0.15.

For the full fiscal year 2019, Zuora is projecting total revenues to be between $220.0 million and $223.0 million. The Company is expecting subscription revenues of $158.0 million to $159.5 million, and a non-GAAP loss from operations of $55.0 million to $52.0 million. Zuora is estimating non-GAAP net loss per share to be in the band $0.62 to $0.59.

Stock Performance Snapshot

June 27, 2018 – At Wednesday’s closing bell, Zuora’s stock declined 1.86%, ending the trading session at $26.96.

Volume traded for the day: 1.63 million shares, which was above the 3-month average volume of 1.12 million shares.

Stock performance in the last month – up 30.43%; and year-to-date – up 34.80%

After yesterday’s close, Zuora’s market cap was at $3.36 billion.

The stock is part of the Technology sector, categorized under the Application Software industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 503953

Stock Research Monitor: DOX, AZPN, and ADP

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on CA sign up now at www.wallstequities.com/registration. On Wednesday, June 27, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Eight out of nine sectors ended Wednesday’s trading session in bearish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Business Software & Services equities this morning: Amdocs Ltd (NASDAQ: DOX), Aspen Technology Inc. (NASDAQ: AZPN), Automatic Data Processing Inc. (NASDAQ: ADP), and CA Inc. (NASDAQ: CA). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Amdocs

On Wednesday, shares in Chesterfield, Missouri headquartered Amdocs Ltd recorded a trading volume of 794,356 shares, which was higher than their three months average volume of 627.40 thousand shares. The stock ended at $66.20, declining 1.78% from the last trading session. The Company’s shares have gained 3.05% in the last twelve months. The stock is trading below its 50-day moving average by 2.00%. Furthermore, shares of Amdocs, which through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide, have a Relative Strength Index (RSI) of 33.88. Get the full research report on DOX for free by clicking below at:

www.wallstequities.com/registration/?symbol=DOX

Aspen Technology

Bedford, Massachusetts headquartered Aspen Technology Inc.’s stock finished yesterday’s session 1.67% lower at $92.77. A total volume of 695,230 shares was traded, which was above their three months average volume of 576.86 thousand shares. The Company’s shares have gained 19.64% over the previous three months and 69.16% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 0.08% and 21.05%, respectively. Furthermore, shares of Aspen Technology, which together with its subsidiaries, provides software and services in the US, Europe, and internationally, have an RSI of 44.21. Get access to our top-rated research, including the free report on AZPN at:

www.wallstequities.com/registration/?symbol=AZPN

Automatic Data Processing

At the close of trading on Wednesday, shares in Roseland, New Jersey headquartered Automatic Data Processing Inc. saw a decline of 1.50%, ending the day at $133.07. The stock recorded a trading volume of 1.66 million shares. The Company’s shares have advanced 19.07% in the previous three months and 31.10% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 3.29% and 12.56%, respectively. Moreover, shares of the Company, which provides business process outsourcing services worldwide, have an RSI of 48.00. Click here to subscribe for a free membership which welcomes you with our report on ADP at:

www.wallstequities.com/registration/?symbol=ADP

CA Inc.

New York headquartered CA Inc.’s shares ended the day 2.38% lower at $35.31 with a total trading volume of 1.97 million shares. The stock has gained 5.47% in the previous three months. The Company’s shares are trading above their 200-day moving average by 3.00%. Additionally, shares of CA Inc., which together with its subsidiaries, develops, markets, delivers, and licenses software products and services in the US and internationally, have an RSI of 39.32. To get free access to your research report on CA, sign up at:

www.wallstequities.com/registration/?symbol=CA

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503969

Stock Research Monitor: CRH, EXP, and ROP

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on CX sign up now at www.wallstequities.com/registration. On Wednesday, June 27, 2018, US markets saw broad based losses with eight out of nine sectors finishing the trading sessions in red. Major US indices were also bearish at the close of yesterday’s session. The NASDAQ Composite ended the day at 7,445.09, down 1.54%; the Dow Jones Industrial Average edged 0.68% lower, to finish at 24,117.59; and the S&P 500 closed at 2,699.63, down 0.86%. This Thursday morning, WallStEquities.com looks at the performance of these four Industrial Goods stocks: CEMEX S.A.B. de C.V. (NYSE: CX), CRH PLC (NYSE: CRH), Eagle Materials Inc. (NYSE: EXP), and Roper Technologies Inc. (NYSE: ROP). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

CEMEX

On Wednesday, shares in San Pedro Garza Garcia, Mexico-based CEMEX S.A.B. de C.V. recorded a trading volume of 9.00 million shares, which was above their three months average volume of 7.98 million shares. The stock ended the session 2.73% lower at $6.42. The Company’s shares have gained 7.54% in the last month. The stock is trading above its 50-day moving average by 3.81%. Moreover, shares of CEMEX, which together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, clinker, and other construction materials, have a Relative Strength Index (RSI) of 57.89. Get the full research report on CX for free by clicking below at:

www.wallstequities.com/registration/?symbol=CX

CRH PLC

Dublin, Ireland headquartered CRH PLC’s stock closed the day 0.97% lower at $35.70 with a total trading volume of 808,565 shares, which was above their three months average volume of 603.05 thousand shares. The Company’s shares have advanced 5.68% in the previous three months. The stock is trading below its 50-day moving average by 2.16%. Additionally, shares of CRH PLC, which through its subsidiaries, manufactures and distributes building materials, have an RSI of 40.96. CRH’s complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=CRH

Eagle Materials

Shares in Dallas, Texas headquartered Eagle Materials Inc. recorded a trading volume of 523,166 shares, which was above their three months average volume of 457.14 thousand shares. The stock ended yesterday’s trading session 1.50% lower at $105.26. The Company’s shares have advanced 15.01% in the past twelve months. The stock is trading below its 50-day moving average by 1.09%. Furthermore, shares of Eagle Materials, which through its subsidiaries, produces and supplies heavy construction materials, light building materials, and materials used for oil and natural gas extraction in the US, have an RSI of 37.33.

On June 13th, 2018, research firm Northcoast upgraded the Company’s stock rating from ‘Neutral’ to ‘Buy’. Register for your free research report on EXP at:

www.wallstequities.com/registration/?symbol=EXP

Roper Technologies

Sarasota, Florida-based Roper Technologies Inc.’s stock finished Wednesday’s session 1.23% lower at $269.89 with a total trading volume of 385,597 shares. The Company’s shares have advanced 17.28% in the past twelve months. The stock is trading above its 200-day moving average by 0.98%. Additionally, shares of Roper Technologies, which designs and develops software, and engineered products and solutions, have an RSI of 35.96. Wall St. Equities’ downloadable research report on ROP available at:

www.wallstequities.com/registration/?symbol=ROP

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503970

Stock Research Monitor: BDSI, BIIB, and BHVN

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want a free Stock Review on CERS sign up now at www.wallstequities.com/registration. On Wednesday, the NASDAQ Composite ended the day at 7,445.09, down 1.54%; the Dow Jones Industrial Average edged 0.68% lower, to finish at 24,117.59; and the S&P 500 closed at 2,699.63, marginally slipping 0.86%. Losses were broad based as eight out of nine sectors finished the trading session in red. WallStEquities.com has initiated research reports on the following Biotechnology stocks: BioDelivery Sciences International Inc. (NASDAQ: BDSI), Biogen Inc. (NASDAQ: BIIB), Biohaven Pharmaceutical Holding Co. Ltd (NYSE: BHVN), and Cerus Corp. (NASDAQ: CERS). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

BioDelivery Sciences International

Raleigh, North Carolina headquartered BioDelivery Sciences International Inc.’s stock finished Wednesday’s session 4.76% lower at $3.00 with a total trading volume of 774,363 shares, which was higher than their three months average volume of 432.62 thousand shares. The stock has gained 22.45% in the past month and 36.36% over the past three months. The Company’s shares are trading above their 50-day and 200-day moving averages by 25.47% and 19.39%, respectively. Moreover, shares of BioDelivery Sciences, which engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction, have a Relative Strength Index (RSI) of 61.54. Get the full research report on BDSI for free by clicking below at:

www.wallstequities.com/registration/?symbol=BDSI

Biogen

Shares in Cambridge, Massachusetts headquartered Biogen Inc. declined 1.37%, ending yesterday’s session at $287.93 with a total trading volume of 911,311 shares. The stock has gained 6.15% over the past twelve months. The Company’s shares are trading above their 50-day moving average by 1.29%. Moreover, shares of Biogen, which discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide, have an RSI of 43.12.

On May 31st, 2018, research firm Canaccord Genuity upgraded the Company’s stock rating from ‘Hold’ to ‘Buy’ while revising its previous target price from $350 a share to $335 a share. Today’s complimentary research report on BIIB is accessible at:

www.wallstequities.com/registration/?symbol=BIIB

Biohaven Pharmaceutical Holding

On Wednesday, New Haven, Connecticut-based Biohaven Pharmaceutical Holding Co. Ltd’s stock saw a drop of 4.81%, to close the day at $38.02. A total volume of 306,589 shares was traded. The Company’s shares have advanced 10.56% in the last month, 56.27% in the previous three months, and 51.72% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 16.18% and 25.92%, respectively. Additionally, shares of Biohaven Pharma, which develops product candidates to treat neurological diseases, including rare disorders, have an RSI of 54.08. Register now for your free research document on BHVN at:

www.wallstequities.com/registration/?symbol=BHVN

Cerus

Shares in Concord, California headquartered Cerus Corp. ended the day 4.75% lower at $6.62. A total volume of 948,294 shares was traded. The stock has gained 19.93% in the previous three months and 170.20% over the last twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 5.43% and 46.64%, respectively. Furthermore, shares of Cerus, which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety, have an RSI of 50.16. Click on the link below and see our free report CERS at:

www.wallstequities.com/registration/?symbol=CERS

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503972